Skip to main content

Table 2 Lipid values in the PPS patients and two reference populations

From: Elevated blood lipids are uncommon in patients with post-polio syndrome – a cross sectional study

  Patients without lipid lowering drugs All patients
  PPS NORIP p PPS Jungner et al p PPS NORIP p
Total cholesterol, mmol/L, all patients 5.9(1.0) 5.9 0.8 5.7(1.0) 6.4 <0.001 5.7(1.0) 5.9 0.09
Total cholesterol, female 6.1(0.9) 5.9 0.07 6.0(1.0) 6.5 0.001 6.0(1.0) 5.9 0.7
Total cholesterol, male 5.5(0.9) 5.9 0.04 5.3(0.9) 6.1 <0.001 5.3(0.9) 5.9 0.001
LDL, mmol/L, all patients 3.8(0.9) 3.6 0.10 - - - 3.6(0.9) 3.6 0.9
LDL, female 4.0(0.9) 3.6 0.03 - - - 3.8(1.0) 3.6 0.4
LDL, male 3.6(0.8) 3.6 0.8 - - - 3.4(0.8) 3.6 0.1
HDL, mmol/L, all patients 1.5(0.4) 1.7 0.001 - - - 1.5(0.4) 1.7 <0.001
HDL, female 1.6(0.4) 1.8 0.01 - - - 1.6(0.4) 1.8 <0.001
HDL, male 1.3(0.4) 1.5 0.02 - - - 1.3(0.4) 1.5 0.003
Triglycerides, mmol/L, all patients 1.3(0.6) 1.5 0.003 1.4(0.7) 1.6 0.05 1.4(0.7) 1.5 0.05
Triglycerides, female 1.2(0.6) 1.5 0.03 1.4(0.8) 1.5 0.5 1.4(0.8) 1.5 0.2
Triglycerides, male 1.4(0.7) 1.5 0.3 1.4(0.6) 1.7 0.007 1.4(0.6) 1.5 0.1
  1. Total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and triglyceride levels in all 89 PPS patients and in 72 PPS patients without lipid lowering medication, as compared to age and gender matched reference mean values, from NORIP and the study by Jungner et al. Mean value and standard deviation (SD).